Delivery of 90,000 meningitis B vaccinations for young people prompts call for annual campaign During the first week of the NHS meningococcal B disease vaccination service, more than 8,200 participating pharmacies received around 135,000 bookings.…
Once-weekly HIV pill performs as well as daily treatment in phase III study Researchers found that a once-weekly tablet combining islatravir and lenacapavir performed as well as the once-daily bictegravir–emtricitabine–tenofovir alafenamide regimen.…
NICE recommends heart drug aficamten with simultaneous MHRA approval The National Institute for Health and Care Excellence said that aficamten is likely to be as effective as mavacamten in treating obstructive hypertrophic cardiomyopathy, with “fewer monitoring scans to find the right dose”.…
ICBs funded for independent prescribing implementation NHS England has published three documents relating to community pharmacist prescribing in 2026/2027.…
Premature menopause increases risk of high blood pressure, study finds Researchers found that based on more than 50 variables, including weight and family history, women with premature menopause had a 12% higher risk of developing hypertension than women who reached menopause after the age of 45 years.…
Local authorities advised to work with pharmacies to improve rural vaccination rates The Local Government Association said that community pharmacies should engage with local directors of public health to close gaps in vaccination coverage.…
Acute kidney injury: causes, diagnosis and management An overview of the symptoms, management options and prescribing considerations for acute kidney injury.…
Prescribing of dependency forming medicines ‘moving in the right direction’ but challenges remain NHS Business Services Authority data reveals that in 2025/2026, the number of prescriptions for opioids decreased by 8% compared with 2016/2017.…
Around one in five adults would share weight-loss jabs with friends, survey finds A Pharmacy2U-commissioned survey also found that more than one-quarter of UK adults said that they would share oral weight-loss medication with friends or family.…
Pharmaceutical companies in talks with NICE about access to Alzheimer’s drugs Drug manufacturers Lilly and Eisai are in discussion with the National Institute for Health and Care Excellence to appeal the regulator’s rejection of the use of donanemab and lecanemab on the NHS for the third time in June 2025.…
